Verastem (VSTM) Competitors

Verastem (NASDAQ:VSTM) and MannKind (NASDAQ:MNKD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, community ranking, risk, analyst recommendations, valuation, earnings and institutional ownership.

Does the media favor VSTM or MNKD?

In the previous week, MannKind had 10 more articles in the media than Verastem. MarketBeat recorded 17 mentions for MannKind and 7 mentions for Verastem. MannKind's average media sentiment score of 0.75 beat Verastem's score of 0.49 indicating that MannKind is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Verastem	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MannKind	8 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is VSTM or MNKD more profitable?

MannKind has a net margin of 8.07% compared to Verastem's net margin of 0.00%. MannKind's return on equity of -17.74% beat Verastem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verastem	N/A	-332.73%	-73.97%
MannKind	8.07%	-17.74%	8.68%

Do analysts prefer VSTM or MNKD?

Verastem presently has a consensus target price of $14.33, suggesting a potential upside of 88.15%. MannKind has a consensus target price of $10.00, suggesting a potential upside of 137.81%. Given MannKind's stronger consensus rating and higher probable upside, analysts plainly believe MannKind is more favorable than Verastem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verastem	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	3.00
MannKind	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Which has more volatility & risk, VSTM or MNKD?

Verastem has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, MannKind has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in VSTM or MNKD?

88.4% of Verastem shares are owned by institutional investors. Comparatively, 49.5% of MannKind shares are owned by institutional investors. 2.1% of Verastem shares are owned by company insiders. Comparatively, 2.7% of MannKind shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer VSTM or MNKD?

Verastem received 30 more outperform votes than MannKind when rated by MarketBeat users. Likewise, 65.36% of users gave Verastem an outperform vote while only 60.41% of users gave MannKind an outperform vote.

Company	Underperform	Outperform
Verastem	Outperform Votes 619 65.36%	Underperform Votes 328 34.64%
MannKind	Outperform Votes 589 60.41%	Underperform Votes 386 39.59%

Which has preferable valuation and earnings, VSTM or MNKD?

MannKind has higher revenue and earnings than Verastem. Verastem is trading at a lower price-to-earnings ratio than MannKind, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verastem	$10M	41.86	-$87.37M	-$3.20	-2.38
MannKind	$297.60M	4.29	-$11.94M	$0.10	42.05

Summary

MannKind beats Verastem on 14 of the 19 factors compared between the two stocks.